August | 2025 | DrugMonkey
11 posts published by drugmonkey during August 2025| DrugMonkey
I have been a bit obsessed with my discovery that a long standing CSR convened study section went through a bad spell. From 2020-2022, NIH funded only seven new (Type 1) R01 per year that were reviewed in this study section. This was a substantial decline from the 22 and 20 grants funded in the […]| DrugMonkey
I was recently pondering the relative funding rates for amended (aka revised) NIH grant proposals, something I haven’t thought about much in years. It used to be quite a theme around here. I got a little pushback from longtime blog friend qaz who laments the passing of Ye Olde Halcyonne Dayes in which the revision […]| DrugMonkey
I know Doctor Editor Director Professor Berg has more sophisticated analyses going but this simple data set made sense to me once I realized how few new R01 NIAAA has issued so far (5). Since we are in a CR that permits spending up to the level of FY 2024, I wanted to know how […]| DrugMonkey
It has been awhile since I last addressed (i.e., complained about) the NIH grant amendment process. This is no doubt because it has similarly been a long time since I looked at funding data by amendment status. In today’s musings about multi-year funding, I started wandering down the amendment path again. What I first noticed […]| DrugMonkey
The NIH continued to issue Notices of Grant Award, including new grants, right up to 8/15. A search of RePORTER shows 322 new (Type 1) grants awarded since 8/9, of which 105 were R01s. Some 58 Type 2 continuations were awarded, 18 of which were R01 and 10 are T32s. This brings us to a […]| DrugMonkey
NOT-OD-25-143 notifies the grant seeking community that it will now be harder and less efficient to stay on top of Notices of Funding Opportunity (NOFOs). Starting in Fiscal Year 2026 all such funding opportunities will only be posted to Grants.gov, which you will have to search (via Classic or “Simpler Search“) yourself. I don’t know […]| DrugMonkey
Three weeks ago, I noted that all of the seventeen Multi-Year Funding R01 issued since July 1 on RePORTER were from NIAID. Now that the records are updated through 8/8, we can see that 40 of the first 42 new R01 issued by NIH from 7/1-7/23 were from NIAID. As one might expect, additional ICs […]| DrugMonkey
Long ago some jerko on the internet responded to growing competition for NIH grant funding in the post-doubling era by suggesting we in the biomedical science disciplines should stop training so many PhD students. The response to this miscreant was rapid and angry and well…..I think we can score most of it as disagreement. It […]| DrugMonkey
Fascist regimes entrench their takeover via fear. Fear of imprisonment. Fear of execution, eventually. But mostly they use fear of losing whatever comforts a member of the nation happens to enjoy. A Program Officer has resigned from NIDA and has explained why in an Op-Ed in Nature. I happen to have positive experiences with her, […]| DrugMonkey
Chatter on the socials today indicates that the NIH’s Director of the Center for Scientific Review is stepping down. [UPDATE 08/08/2025: NIH Director statement on Byrnes’ retirement.] N…| DrugMonkey
Following up on yesterday’s whinesplaining about the relative difficulty of getting a NIH grant across pertinent career eras, I had some more thoughts on generational expectations and gasligh…| DrugMonkey
There’s a parable about a coyote and a rabbit that ends with the coyote being criticized by a bystander after observing his fruitless chase. The coyote observed, “I was only running for…| DrugMonkey
NIH has issued NOT-OD-25-132 Supporting Fairness and Originality in NIH Research Applications which informs us that NIH will only accept six new, renewal, resubmission, or revision applications fro…| DrugMonkey
I ran across a clip of the current Director of the NIH and the prior Acting Director (and current Principal Deputy Director of the NIH) expressing great concern about scientists in training. As per…| DrugMonkey
As you might expect, I have been following the NIH funding opportunity issued under PAR-22-181 Research Opportunities for New and “At-Risk” Investigators to Promote Workforce Diversity …| DrugMonkey
I know I shouldn’t let the state of the alleged profession of journalism bother me. It is clearly a lost cause at this point. But someone served up a juicy serving of stupidity on the blusky …| DrugMonkey
My original observation that the NIH ICs do not fund Cycle I grants on time (i.e., by Dec 1) under Continuing Resolutions in the absence of Congress acting on an appropriation has been modified in …| DrugMonkey
Way back in 2015 the NIH made some major changes to the Biosketch. As detailed in this post, one of the major changes was replacing the long list of publications with a “contribution to scien…| DrugMonkey
